Accepted at 8:25 p.m. Oct, 31, 2023 by Alex
Author: nicecube
Related Note: 1480564293791
Rationale for change

First aid 2022 page 440 says myeloproliferative and not myelodysplastic

#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::03_Polycythemia_Vera_&_Essential_Thrombocythemia #AK_Step2_v12::#OME::01_Medicine::05_Hematology_Oncology::05_Leukemia #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::03_Leukemia #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::27_Myelodysplastic_syndromes #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::01_Acute_Myelogenous_Leukemia_(AML) #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::03_White_Cells::02_Myeloproliferative_Disorders #AK_Step1_v12::#AMBOSS::41a3Sj #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::10_Plasma_Cell_Dyscrasias_&_Myeloproliferative_Disease::04_Myelofibrosis_and_Myelodysplastic_Syndromes !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-WBC #AK_Step2_v12::#AMBOSS::KS0U0f #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::14_Myeloproliferative_Disorders #AK_Step2_v12::Original_decks::Dorian::im::ome::heme/onc::leukemia #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::12_Acute_Leukemia #AK_Step2_v12::#Resources_by_rotation::IM::ome::heme/onc::leukemia !AK_UpdateTags::AnKing_Image::Mujeeb #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::09_Leukemias_and_Lymphomas::01_Acute_Myeloid_Leukemia !AK_UpdateTags::AnKing_Image::Mujeeb::Leukemia_and_Lymphoma_Overview #AK_Step1_v12::#B&B::11_Hematology::03_White_Blood_Cells::01_Acute_Leukemia::Extra #AK_Step1_v12::^Other::^HighYield::3-HighYield-temporary #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::01_Acute_Leukemias_SOAP #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::28_Leukemias::*Leukemia::Acute_Leukemia::Acute_Myelogenous_Leukemia::Myelodysplastic_Syndromes #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::04_Proliferation::03_Leukemia #AK_Step1_v12::^Systems::HemeOnc::WBC #AK_Step1_v12::#Pathoma::06_WBC::02_Acute_Leukemia #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::01_Myeloproliferative_Neoplasms_&_Myelodysplastic_Syndromes #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_WBC #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::28_Leukemias::*Leukemia::Acute_Leukemia::Acute_Myelogenous_Leukemia::Basics #AK_Step2_v12::#AMBOSS::vt0A23 #AK_Step1_v12::#SketchyPath::10_Myeloid_&_Lymphoid::01_Myeloid_Disorders::02_Acute_Myeloid_Leukemia_(AML)_&_Chronic_Myeloid_Leukemia_(CML)